How much revenue does Micro-Tech (Nanjing) make?

Micro-Tech (Nanjing) reported 2.76 billion CNY in revenue for fiscal year 2024, up 14.5% from 2.41 billion CNY in fiscal year 2023. In Q2 2025 revenue was 866.22 million CNY.

Where does Micro-Tech (Nanjing) make most of its revenue?

China: 50% of revenue by region in fiscal year 2024, followed by Export (50%).

What companies are similar to Micro-Tech (Nanjing)?

Listed companies of a similar size in the same industry (targeted healthcare equipment) include Shanghai MicroPort Endovascular MedTech Co., Ltd. (688016.SS), Autek China Inc. (300595.SZ), Eyebright Medical Technology (Beijing) Co., Ltd. (688050.SS), Mingyue Optical Lens Co.,Ltd. (301101.SZ).

Micro-Tech (Nanjing) Co.,Ltd (688029.SS) Stock

About Micro-Tech (Nanjing) Co.,Ltd

Micro-Tech (Nanjing) Co.,Ltd, together with its subsidiaries, engages in the research, development, manufacturing, and sale of minimally invasive medical devices in China and internationally. The company offers digestive endoscopy products, including ESD, such as electric flushing device, harmony/GT gold clip, gold/titanium knife, pull clamp, three-arm clap, hemostatic titanium forceps, injection ...

At a glance

Micro-Tech (Nanjing) reported revenue of 2.76 billion CNY for fiscal year 2024, up 14.5% from fiscal year 2023, and net income of 553.23 million CNY. In Q2 2025 (the quarter ended June 30, 2025) revenue was 866.22 million CNY, up 21.4% from a year before. China was its largest region in fiscal year 2024, with 50% of revenue.

Figures from company filings; latest fiscal year ended December 31, 2024.

No profile data available.

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.